D-0074-2023 Class III Terminated
FDA drug recall D-0074-2023 was initiated by Acella Pharmaceuticals, LLC on Nov 14, 2022 and is designated Class III. Reason for recall: Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period. The recall status is terminated (terminated Aug 1, 2024). Affected quantity: 528 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 7, 2022
- Initiation Date
- Nov 14, 2022
- Termination Date
- Aug 1, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 528 cartons
Product description
Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net weight 3.7 g each per carton,) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 300025, NDC 42192-113-60
Reason for recall
Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.
Distribution pattern
USA Nationwide
Code information
Lot#: 21084, 21085, Exp 06/30/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0074-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026